Latigo Biotherapeutics
Uniquely poised to disrupt pain therapy
Thousand Oaks, United States · Founded 2018
- Headquarters
- Thousand Oaks, California
- Founded
- 2018
- Business Model
- B2B
- Website
- latigobio.com
About
Latigo Biotherapeutics is a clinical-stage biopharmaceutical company developing innovative non-opioid pain medicines that target pain at its source. Its lead candidate, LTG-001, is a potential best-in-class Nav1.8 inhibitor granted FDA Fast Track designation. Based in Thousand Oaks, California, Latigo has raised a $135M Series A and $150M Series B to advance its pipeline.
Summary
Latigo Biotherapeutics is a Biotech company based in Thousand Oaks, United States, founded in 2018.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...